DICLOFENAC POTASSIUM (DICLOFENAC POTASSIUM) — FDA Approval ANDA213875 (AUROBINDO PHARMA LTD)
DICLOFENAC POTASSIUM (DICLOFENAC POTASSIUM) — FDA Approval ANDA213875 (AUROBINDO PHARMA LTD) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: DICLOFENAC POTASSIUM; Active ingredients: DICLOFENAC POTASSIUM; Application number: ANDA213875.
| Brand name | DICLOFENAC POTASSIUM |
|---|---|
| Active ingredients | DICLOFENAC POTASSIUM |
| Application number | ANDA213875 |
| Sponsor | AUROBINDO PHARMA LTD |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20211019 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →